156 related articles for article (PubMed ID: 19413671)
1. Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers.
Yang YY; Lee KC; Huang YT; Lee FY; Chau GY; Loong CC; Lin HC; Lee SD
Liver Int; 2009 May; 29(5):678-85. PubMed ID: 19413671
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide decreases intrahepatic resistance in cirrhotic rats.
Yang YY; Huang YT; Lin HC; Lee FY; Lee KC; Chau GY; Loong CC; Lai CR; Lee SD
Biochem Biophys Res Commun; 2009 Mar; 380(3):666-72. PubMed ID: 19285019
[TBL] [Abstract][Full Text] [Related]
3. The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
Lin HC; Yang YY; Tsai TH; Huang CM; Huang YT; Lee FY; Liu TT; Lee SD
J Hepatol; 2011 Jun; 54(6):1145-53. PubMed ID: 21145843
[TBL] [Abstract][Full Text] [Related]
4. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Clin Sci (Lond); 2007 May; 112(10):533-42. PubMed ID: 17176248
[TBL] [Abstract][Full Text] [Related]
6. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
7. Roles of anandamide in the hepatic microcirculation in cirrhotic rats.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G328-34. PubMed ID: 16407591
[TBL] [Abstract][Full Text] [Related]
8. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
[TBL] [Abstract][Full Text] [Related]
9. Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis.
Yang YY; Lee KC; Huang YT; Wang YW; Hou MC; Lee FY; Lin HC; Lee SD
J Hepatol; 2008 Jul; 49(1):25-33. PubMed ID: 18490076
[TBL] [Abstract][Full Text] [Related]
10. Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.
Yang YY; Tsai TH; Huang YT; Lee TY; Chan CC; Lee KC; Lin HC
Hepatology; 2012 May; 55(5):1540-50. PubMed ID: 22183953
[TBL] [Abstract][Full Text] [Related]
11. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Gaskari SA; Liu H; Moezi L; Li Y; Baik SK; Lee SS
Br J Pharmacol; 2005 Oct; 146(3):315-23. PubMed ID: 16025138
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J
Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
[TBL] [Abstract][Full Text] [Related]
14. Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids.
Gaskari SA; Liu H; D'Mello C; Kunos G; Lee SS
J Hepatol; 2015 Jun; 62(6):1272-7. PubMed ID: 25640062
[TBL] [Abstract][Full Text] [Related]
15. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
16. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
17. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
Yang YY; Huang YT; Tsai TH; Hou MC; Lee FY; Lee SD; Lin HC
Clin Sci (Lond); 2012 Dec; 123(12):669-80. PubMed ID: 22734967
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
[TBL] [Abstract][Full Text] [Related]
19. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.
Shibamoto T; Kamikado C; Koyama S
Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271
[TBL] [Abstract][Full Text] [Related]
20. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
Domenicali M; Ros J; Fernández-Varo G; Cejudo-Martín P; Crespo M; Morales-Ruiz M; Briones AM; Campistol JM; Arroyo V; Vila E; Rodés J; Jiménez W
Gut; 2005 Apr; 54(4):522-7. PubMed ID: 15753538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
